| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/27/1995 | CA2173333A1 Combination of bisphosphonates and growth hormone secretagogues |
| 04/27/1995 | CA2171332A1 Pyridazino quinoline compounds |
| 04/27/1995 | CA2170735A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 04/27/1995 | CA2134179A1 Pyrrolidine derivatives inhibitors of leukotriene biosynthesis |
| 04/26/1995 | EP0649854A1 Bisconjugates comprising two saccharides and a spacer |
| 04/26/1995 | EP0649839A1 Isoquinolinone-, phthalazinone-, quinazolinone- and benzotriazolinone derivatives, their preparation and their use as anti-thrombotics |
| 04/26/1995 | EP0649658A1 Method of tumor treatment |
| 04/26/1995 | EP0649654A1 Use of a combination of an ACE-inhibitor with a calcium antagonist in the treatment of proteinuria |
| 04/26/1995 | EP0649650A1 Bioadhesive pharmaceutical composition for controlled release of drugs |
| 04/26/1995 | EP0649432A1 Fluorine comprising dipeptides as inhibitors against human leucocyte elastase inhibitors |
| 04/26/1995 | EP0649419A1 N-cycloalkylpiperazine derivatives, methods of obtaining them and pharmaceutical compositions containing them |
| 04/26/1995 | EP0649418A1 7-(2-aminoethyl)-benzothiazolones |
| 04/26/1995 | EP0649413A1 Uracil derivatives as enzyme inhibitors |
| 04/26/1995 | EP0649412A1 Pharmaceutical pyridine compounds |
| 04/26/1995 | EP0649408A1 Process for making phenylthiomethylpyridinylalkenoates |
| 04/26/1995 | EP0649309A1 Use of particles of a biocompatible, bioabsorbable calcium salt as active principle in the preparation of a medicament for local treatment of bone demineralizing diseases |
| 04/26/1995 | EP0649304A1 Composition and methods for decreasing muscle breakdown |
| 04/26/1995 | EP0649303A1 Substituted arginines and substituted homoarginines and use thereof |
| 04/26/1995 | EP0580782A4 An anti-hiv protein, tap 29, from trichosanthes, dna coding therefor and therapeutic uses thereof. |
| 04/26/1995 | EP0572437B1 2,4-diaminoquinazolines derivatives for enhancing antitumor activity |
| 04/26/1995 | EP0533724B1 Calcium citrate malate composition |
| 04/26/1995 | EP0515510B1 Hydroquinone amino-acid esters, method of preparation, and pharmaceutical or cosmetic compositions containing them |
| 04/26/1995 | EP0505468B1 Imidazole derivatives and their use as acyl coenzyme-a inhibitors |
| 04/26/1995 | CN1102040A Quinoline-3-acetic acid derivative, process for producing the same, and use thereof |
| 04/26/1995 | CN1101915A New 19-nor steroids having a phenoxyalkylsulphonamide or phenoxyalkylsulphonylurea chain in position llbeta, preparation process and intermediates, use as medicaments and pharmaceutical compositions.. |
| 04/26/1995 | CN1101908A Angiotensin II antagonists |
| 04/25/1995 | US5410080 Treating breast cancer |
| 04/25/1995 | US5410061 Pharmaceutical compounds |
| 04/25/1995 | US5410057 1-heteroarylazetidines and -pyrrolidines |
| 04/25/1995 | US5410049 Benzodiazepine derivatives, compositions containing them and their use in therapy |
| 04/25/1995 | US5410018 Bombesin-related peptides |
| 04/25/1995 | US5409956 A sulfonylaminoalkylindan carboxylic acid or ester for treating thrombosis, vasospasm or asthma |
| 04/25/1995 | US5409949 Methylen-oxindole derivatives compositions and tyrosine kinase inhibition therewith |
| 04/25/1995 | US5409947 Treating hypertension, congestive heart failure |
| 04/25/1995 | US5409945 Benzyo-fused thiazolidinyl terminated alkylamino ethylnyl alanine amino diol compounds for treatment of hypertension |
| 04/25/1995 | US5409931 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents |
| 04/25/1995 | US5409925 Oxazobicyclo terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 04/25/1995 | US5409924 Benzo-fused oxazobicyclo terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 04/25/1995 | US5409922 Renin inhibitors |
| 04/25/1995 | US5409921 Renin inhibitors |
| 04/25/1995 | US5409913 Oxazocinyl/thiazocinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 04/25/1995 | US5409911 Prostaglandin analog for treating osteoporosis |
| 04/25/1995 | US5409910 Treating hyperlipoproteinemia and arteriosclerosis |
| 04/25/1995 | US5409899 Pseudopeptide compounds having anti-inflammatory activity |
| 04/25/1995 | US5409702 Cosmetics |
| 04/25/1995 | US5409701 From flexibacter culture; human leukocyte elastase inhibitor |
| 04/25/1995 | CA1335379C Aralkylaminoalkoxyphenyl derivatives, process of preparation and compositions containing the same |
| 04/25/1995 | CA1335378C Alkylaminoalkoxyphenyl derivatives, process of preparation and compositions containing the same |
| 04/23/1995 | CA2133939A1 1,2-dihydro-2-oxo-pyridines |
| 04/23/1995 | CA2132883A1 1-amino-ethylindole-derivatives |
| 04/20/1995 | WO1995010539A1 Growth differentiation factor-10 |
| 04/20/1995 | WO1995010532A1 Compounds useful in anti-allergy treatment |
| 04/20/1995 | WO1995010531A1 Oligopeptides derived from c-reactive protein fragments |
| 04/20/1995 | WO1995010517A1 Indole derivatives as nmda antagonists |
| 04/20/1995 | WO1995010513A1 Benzothiophenes and related compounds as estrogen agonists |
| 04/20/1995 | WO1995010307A1 Radiation sensitization using texaphyrins |
| 04/20/1995 | WO1995010286A1 Inhibitors of phosphoinositide-specific phospholipase c |
| 04/20/1995 | WO1995010271A2 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 04/20/1995 | CA2173856A1 Compounds useful in anti-allergy treatment |
| 04/20/1995 | CA2173456A1 Inhibitors of phosphoinositide-specific phospholipase c |
| 04/20/1995 | CA2173243A1 Benzothiophenes and related compounds as estrogen agonists |
| 04/20/1995 | CA2171546A1 Growth differentiation factor-10 |
| 04/20/1995 | CA2171449A1 Indole derivatives as nmda antagonists |
| 04/20/1995 | CA2112871A1 Preparation process of imidazole sulfur derivatives and new intermediate products obtained |
| 04/19/1995 | EP0648767A1 Piperdine and piperazine derivatives which affect the C.N.S. |
| 04/19/1995 | EP0648763A1 Process for the preparation of sulfur derivatives of imidazole and intermediates obtained |
| 04/19/1995 | EP0648759A1 Antihistaminic compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/19/1995 | EP0648745A1 Arylalkylamine having anticonvulsant and neuroprotective properties |
| 04/19/1995 | EP0648741A1 1,2,3,4-Tetrahydronaphthalene, chroman and thiochroman derivatives as antithrombotic agents |
| 04/19/1995 | EP0648503A1 Pro-prodrugs, their production and use |
| 04/19/1995 | EP0648501A1 Compositions comprising G-CSF for treating or preventing infections in canine and feline animals |
| 04/19/1995 | EP0648496A1 Therapeutic compositions for use in the treatment of skin lesions and method of making same |
| 04/19/1995 | EP0648493A1 A method to reverse the phenotype of transformed cells by the transcription factor IRF-1 |
| 04/19/1995 | EP0648489A1 Arylalkylamides having neuroprotective properties |
| 04/19/1995 | EP0648488A1 Method to alter hairgrowth and compositions therefor |
| 04/19/1995 | EP0648261A1 A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector |
| 04/19/1995 | EP0648213A1 Benzothiazepine and benzoxazepine derivatives as cholecystokinin receptor antagonists |
| 04/19/1995 | EP0648209A1 Contrast agents for mr diagnosis |
| 04/19/1995 | EP0648208A1 Indole derivatives as testosterone 5 alpha-reductase inhibitors |
| 04/19/1995 | EP0648206A1 Peptidyl derivatives and their use as metalloproteinase inhibitors |
| 04/19/1995 | EP0648122A1 PREVENTING TISSUE ADHESION USING -i(IN SITU) MODIFICATION OF ALGINATE. |
| 04/19/1995 | EP0648120A1 Use of phosphonates for the treatment of osteoporosis |
| 04/19/1995 | EP0560868B1 Indan derivatives |
| 04/19/1995 | EP0550635B1 Fused ring analogs of nitrogen containing nonaromatic heterocycles |
| 04/19/1995 | EP0509009B1 Use of a material, the main constituent of which is a triglyceride, as an agent with biological effect on the intestinal mucosa and preparation containing such agent |
| 04/19/1995 | EP0497915B1 hPTH (1-37) FRAGMENT, ITS PRODUCTION, DRUG CONTAINING IT AND ITS USE |
| 04/19/1995 | EP0468042B1 HOMOLOGATED VITAMIN D2 COMPOUNDS AND THE CORRESPONDING 1alpha-HYDROXYLATED DERIVATIVES |
| 04/19/1995 | CN1101644A Thiadiazinones |
| 04/19/1995 | CN1028237C Composition for stimulating chondrocytes and osteoblasts, method for its production |
| 04/18/1995 | US5408041 Multiple elutions with Sepharose, Sephacryl, HPLC; for bone disorders, osteoporosis, Paget*s disease |
| 04/18/1995 | US5407956 Hypotensive agents, kidney disorders |
| 04/18/1995 | US5407952 Azole derivatives, pharmaceutical compositions containing the same, and method for treating mycosis and estrogen-dependent diseases |
| 04/18/1995 | US5407948 Substituted mono- and bipyridylmethylpyridones |
| 04/18/1995 | US5407946 Pyrrolidine compounds which are useful as thromboxane AZ-inhibitors |
| 04/18/1995 | US5407941 Platelet activating factor antagonist and antihistamine; useful for treating asthma and allergic disorders |
| 04/18/1995 | US5407935 Pharmaceutical composition for and a method of using a combination of an uricosuric agent and an EAA antagonist |
| 04/18/1995 | US5407915 Human Bikunin variants as proteinase inhibitors, and medicaments containing these |
| 04/18/1995 | US5407823 Polypeptides having a dopaminergic receptor activity, nucleic acids coding for these polypeptides and use of these polypeptides for the screening of substances active on these polypeptides |
| 04/18/1995 | US5407821 Genetic diagnosis of torsion dystonia |
| 04/18/1995 | US5407688 Compositions and methods for treating gastrointestinal disorders |